Differences in the experience of fatigue in patients and healthy controls: patients' descriptions

1477-7525-5-36 1477-7525 Research Differences in the experience of fatigue in patients and healthy controls: patients' descriptions Gielissen F Marieke m.gielissen@nkcv.umcn.nl Knoop Hans j.knoop@nkcv.umcn.nl Servaes Petra p.servaes@ULC.umcn.nl Kalkman S Joke j.kalkman@ULC.umcn.nl Huibers J Marcus M.Huibers@DMKEP.unimaas.nl Verhagen Stans C.Verhagen@ONCO.umcn.nl Bleijenberg Gijs g.bleijenberg@nkcv.umcn.nl

Expert Centre Chronic Fatigue Nijmegen, Radboud University, Nijmegen Medical Centre, The Netherlands

Department of medical, clinical and experimental psychology, Maastricht University, The Netherlands

Department of Medical Oncology of the Radboud University Nijmegen Medical Centre, The Netherlands

Health and Quality of Life Outcomes 1477-7525 2007 5 1 36 http://www.hqlo.com/content/5/1/36 17605783 10.1186/1477-7525-5-36 25 1 2007 02 7 2007 02 7 2007 2007 Gielissen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

the primary objective was to develop an adjective checklist, the Fatigue Quality List (FQL), aimed at assessing different perceptions of fatigue.

Methods

961 participants filled out the FQL (28 adjectives). A component and confirmatory factor analyses were performed and psychometric properties were evaluated. Differences on factor scores between different patients' groups were investigated and pre- and post treatment scores were compared in demonstrating change of perceptions after treatment of fatigue.

Results

Four independent factors were found with adequate psychometric properties. Different perceptions were found between the patients' groups. Patients who were recovered after treatment for fatigue showed similar scores on the factors as healthy controls.

Conclusion

The FQL appears to be a promising tool in measuring different perceptions of fatigue, which can be especially interesting for clinical practice.

Background

What is meant by fatigue? Most people are familiar with the experience of fatigue, but the meaning of this sensation can differ between people and even within one person the meaning of fatigue can change. Therefore, fatigue can be defined in different ways and there is no 'gold standard'. Healthy people would characterise fatigue as a pleasant, acute, normal and regulating phenomenon after exercise or a busy day, disappearing after a good night's sleep or a period of rest. However, fatigue can also have a more negative connotation as in fatigue experienced by patients with a health problem. To them fatigue can be a chronic, disabling and life- and activity-limiting experience 123456.

There are also differences in the factors underlying fatigue severity between patients with different somatic conditions. Processes involved in the experience of fatigue in patients with chronic fatigue syndrome (CFS) are clearly different from processes related to the experience of fatigue in patients with multiple sclerosis (MS) 2 and there are many differences between severely fatigued breast cancer survivors and females with CFS 7.

Because fatigue is not clearly defined, poor communication regarding fatigue exist in the clinical practice 8. Additionally, health care professionals find consultations on fatigue difficult and are often dissatisfied with or uncertain about the care they provide to patients with fatigue complaints 910. Without appropriate assessment, recognition and providing the proper management to patients with chronic fatigue is difficult. The first necessary step towards improving recognition and management is a thorough understanding of the symptom.

Until now fatigue scales are mostly used to measure fatigue severity 11. However, fatigue severity does not reflect a persons' perception and appraisal of the fatigue. Therefore, the quantitative way of assessing fatigue fails to capture the nuances and differences in the experience of fatigue. In pain research assessment methods already exists in determining the quality of pain in a patient by using adjectives 1213.

In this study an adjective checklist, the Fatigue Quality List (FQL), was constructed aimed at assessing different perceptions of fatigue. The development of the FQL was described and additionally three research questions were investigated:

1. Is the FQL a reliable and valid instrument to assess different perceptions of fatigue?

2. Are perceptions of fatigue different between several patient groups with and without chronic fatigue complaints and healthy controls?

3. Do perceptions of fatigue change in patients who recover after treatment for fatigue?

Methods

Materials

Fatigue Quality List

Researchers and clinicians working at the Expert Centre Chronic Fatigue of the Radboud University Nijmegen Medical Centre made a large list of all possible adjectives that can be used to characterize the feeling of fatigue. The FQL was developed by asking researchers and health care professionals working with patients with unexplained fatigue complaints to indicate on this large list which of the adjectives best fitted with the experience of the fatigue described by their patients. The final list consisted of 28 adjectives most frequently mentioned by the raters.

In filling out the FQL, subjects are instructed to mark with a cross which of the 28 adjectives fit their experienced fatigue. Multiple answers are possible. In this study the Dutch version of the FQL was used. However, the adjectives were translated into English by a back-translation procedure.

Fatigue severity was measured by a subscale of the Checklist Individual Strength (CIS-fatigue) consisting of 8 items 14. Each item was scored on a 7-point Likert scale. High scores indicated a high level of fatigue severity. Based on research with Chronic Fatigue Syndrome patients, a score of 35 or higher on the subscale fatigue severity indicated severe feelings of fatigue. Furthermore, the CIS has excellent psychometric properties 111.

Patients

Nine-hundred-sixty-one participants with a mean age of 43.6 years (sd = 10.2, range 18–79) predominantly female (65%) filled out the FQL. All were either patients or healthy controls participating in scientific studies conducted by the Expert Centre Chronic Fatigue. The total group consisted of:

- 219 cancer survivors. Hundred-twenty-eight (mean age 44.8 (sd = 8.9); female 72%) experienced severe chronic fatigue and 91 (mean age 46.5 (sd = 6.3); female 100%) were not fatigued 3. Forty-one of these cancer survivors were participating in a randomised control trial about the effectiveness of cognitive behaviour therapy (CBT) especially designed to reduce chronic fatigue in cancer survivors 15. These patients filled out the FQL at pre- and post treatment.

- 160 patients who were diagnosed with Chronic Fatigue Syndrome (CFS), according to the CDC criteria (mean age 38.0 (sd = 10.7); female 69%) 416. Eighty-two CFS patients who were included in this study were treated for their chronic fatigue complaints with CBT 4. These patients filled out the FQL two times, at pre- and post treatment.

- 151 employees on sick leave with unexplained fatigue complaints (mean age 44.0 (sd = 8.4); female 55%) 17. 66 (44%) of these met research criteria for CFS (mean age 42.9 (sd = 8.6); female 61%).

- 276 patients with various neuromuscular disorders. Hundred-sixty-five experienced severe fatigue (mean age 42.2 (sd = 10.6); female 48%) and 120 experienced no fatigue complaints (mean age 42.2 (sd = 11.3); female 48%) 518

- 77 patients who were diagnosed with pancreatitis. Fifty-three experienced severe fatigue (mean age 49.3 (10.0); female 47%) and 24 were not fatigued (mean age 50.2 (sd = 15.5); female 58%).

- 78 healthy persons who experienced no fatigue complaints (mean age 48.2 (6.2); female 100%) 3.

Statistical analysis

Data analysis was performed using SPSS (version 12.0.1). The total participant group was randomly divided into two groups. A principal component factor analysis was performed in the first group to identify independent factors. A varimax rotation was used to facilitate the interpretation. Furthermore, factor loadings had to be above .40 with a .10 or greater difference in loadings with the other factors. The scree test and the eigenvalues (above 1) were used to identify the number of factors. The factor model was then tested in the second group by using confirmatory factor analyses/AMOS 5.0 (Comparative Fit Index, Goodness of Fit Index, Adjusted Goodness of Fit Index 1920).

The internal consistency reliability for each factor was calculated using Cronbach's alpha. Spearman's rho correlations were used to evaluate psychometric properties of the FQL. To investigate the differences between the groups of patients Kruskal-Wallis tests were performed. When the Kruskal-Wallis test was significant, Mann-Whitney-U tests between the groups followed. The sensitivity to change of the FQL was demonstrated by comparing cancer survivors and CFS patients at pre- and post treatment assessment, using the Wilcoxon Signed Ranks Test of matched pairs. To correct for the multiple comparisons, p-value was set on < 0.01.

Results

Factor solution

Three of the 28 adjectives were marked with a cross for less than 10% and therefore excluded from further analyses. Final analyses were done with the remaining 25 adjectives. Table 1 presents the final factor solution in the first group (n = 476). Seven adjectives were excluded of factor analysis because factor loadings were < .40 and/or <.10 difference in loadings with the other factors. Both the scree test and eigenvalues indicated a 4-factor solution (Table 2). Factor 1 consisted of 5 adjectives, factor 2 of 4 adjectives, factor 3 of 5 adjectives and factor 4 of 4 adjectives, explaining respectively, 24%, 9%, 6%, 5% of the variance prior to rotation. After rotation the four factors explained respectively, 13%, 12%, 10% and 9% of the variance. Factor 1 was labelled as 'Frustrating', Factor 2 as 'Exhausting', Factor 3 as 'Pleasant' and Factor 4 as 'Frightening'. This four factor model was then tested in the second group (n = 485) by using confirmatory factor analysis. The fit indices indicated an adequate fit. Chi-square (129, n = 485) = 364.5, p < 0.001; Comparative Fit Index = .87; Goodness of Fit Index = .92; Adjusted Goodness of Fit Index = .90.

Table 1

Final factor solution: principal-components analysis with varimax-rotation in the first group. Cronbach's Alpha of the four factors

Frustrating

Exhausting

Pleasant

Frightening

discouraging

.735

incessant

.585

annoying

.680

persistent

.559

frustrating

.704

exhausting

.690

wearisome

.537

extreme

.724

unbearable

.509

temporary

.400

relaxing

.661

fulfilling

.713

normal

.522

pleasant

.792

upsetting

.727

frightening

.618

inexplicable

.490

insuperable

.444

Cronbach's Alpha

.79

.68

.61

.57

Three adjectives were excluded of factor analysis because they were marked with a cross for less than 10%: Protective, Soothing, Threatening. Seven adjectives were excluded of factor analysis because factor loadings <.40 and/or <.10 difference in loadings with the other factors: Demanding, Paralysing, Aggravating, Compelling, Treacherous, Insoluble, Acceptable

Table 2

principal-components analysis with varimax-rotation, initial eigenvalues

component

Eigenvalues

4.788

1.906

1.285

1.176

0.984

0.875

0.813

0.742

0.714

0.664

0.623

0.593

0.568

0.514

0.503

0.445

0.428

0.380

The four factors were recoded on a 0 to 100 scale, facilitating comparisons between the factors. Higher scores indicate a higher appraisal of the fatigue experience as frustrating, exhausting, pleasant and frightening. The final version of the FQL and the criteria for scoring are presented in appendix A.

Is the FQL a reliable and valid instrument to assess different perceptions of fatigue?

For each factor the internal consistency reliability was calculated in the entire sample of 961 participants, which demonstrated moderate to adequate internal consistencies for all four factors, ranging from .57 to .79 (Table 1).

Supporting convergent validity we found that all four factors were statistically significant related to fatigue severity (CIS-fatigue) (Table 3).

Table 3

Convergent validity of the 4 factors. Spearman's rho correlation in total group (N = 961)

Factor

Frustrating

Exhausting

Pleasant

Frightening

Fatigue Severity

.66*

.58*

-.54*

.43*

Exhausting

.54*

Pleasant

-.48*

-.35*

Frightening

.49*

.42*

-.25*

Age

-.16*

-.14*

.05

-.03

Gender (1 = M, 2 = F)

-.09*

.03

.11*

-.10*

* p < 0.01

In calculating general psychometric properties statistically significant intercorrelations between the four factors were found (Table 3). Additionally, low correlations were found between the four factors and age and gender, explaining less than 3% of the variance.

Are the perceptions of fatigue different between several patient groups with and without chronic fatigue complaints and healthy controls?

The non-fatigued groups scored significantly lower on Frustrating, Exhausting and Frightening and significantly higher on Pleasant compared with the fatigued groups (Table 4). The following analyses were performed separately in the fatigued groups and the non-fatigued groups.

Table 4

Mean score on 4 factors: comparisons between fatigued disease-free cancer patients, CFS patients, employees with unexplained fatigue, fatigued patients with neuromuscular disease, fatigued patients with pancreatitis, non-fatigued disease-free cancer patients, non-fatigued patients with neuromuscular disease, non-fatigued patients with pancreatitis and healthy persons

Frustrating

Exhausting

Pleasant

Frightening

A. Fatigued disease-free cancer patients

48.6 (30.9)^b,c

29.3 (28.6)^b,d

11.7 (17.7)^b,c

22.7 (24.2)^d,e

B. Chronic fatigue syndrome

58.5 (32.2)^a,d,e

37.8 (31.5)^a,c,d,e

6.6 (13.0)^a,c,d

25.2 (25.9)^d,e

C. Employees with unexplained fatigue

63.7 (29.2)^a,d,e

29.5 (28.1)^b,d

4.3 (11.2)^a,b,d,e

26.0 (26.6)^d,e

D. Fatigued patients with neuromuscular disease

41.8 (32.6)^b,c

17.8 (24.8)^a,b,c

13.6 (18.5)^b,c

13.8 (20.1)^a,b,c

E. Fatigued patients with pancreatitis

41.1 (33.1)^b,c

25.9 (29.8)^b

9.1 (13.9)^c

14.2 (22.7)^a,b,c

F. Non-fatigued disease-free cancer patients

8.1 (16.3)

6.6 (14.4)^g

38.9 (28.3)^g

7.7 (17.0)

G. Non fatigued patients with neuromuscular disease

9.0 (16.2)

1.7 (7.1)^f,h

24.7 (21.3)^f,I

5.6 (13.9)

H. Non-fatigued patients with pancreatitis

13.3 (28.1)

9.4 (17.8)^g

29.2(23.6)

5.2 (12.7)

I. Healthy persons

7.7 (18.3)

3.9 (13.4)

36.2 (23.3)^g

3.2 (10.2)

a. significantly different from group A, Mann-Whitney test p < 0.01

b. significantly different from group B, Mann-Whitney test p < 0.01

c. significantly different from group C, Mann-Whitney test p < 0.01

d. significantly different from group D, Mann-Whitney test p < 0.01

e. significantly different from group E, Mann-Whitney test p < 0.01

f. significantly different from group F, Mann-Whitney test p < 0.01

g. significantly different from group G, Mann-Whitney test p < 0.01

h. significantly different from group H, Mann-Whitney test p < 0.01

i. significantly different from group I, Mann-Whitney test p < 0.01

Frustrating

The non-fatigued groups were similar with respect to the mean scores on Frustrating (p = 0.757). Patients with chronic fatigue syndrome and employees with unexplained fatigue scored significantly higher on Frustrating with respect to the other fatigued groups.

Exhausting

The non-fatigued patients with various neuromuscular disorders scored significantly lower on Exhausting than the non-fatigued cancer survivors and the non-fatigued patients with pancreatitis. Between the fatigued groups, CFS patients scored significantly higher on Exhausting than the other groups. Furthermore, fatigued patients with pancreatitis scored significantly lower with respect to fatigued cancer survivors and employees with unexplained fatigue. Additionally, patients with neuromuscular disorders scored significantly lower than employees with unexplained fatigue.

Pleasant

In the non-fatigued group patients with various neuromuscular disorders scored significantly lower on Pleasant than non-fatigued cancer survivors and healthy persons. In the fatigued group employees with unexplained fatigue scored significantly lower on Pleasant than the other groups. CFS patients scored significantly lower than cancer survivors and patients with neuromuscular disorders.

Frightening

The scores on Frightening in the non-fatigued groups were similar. In the fatigued groups a dichotomy was found between the patients with unexplained fatigue with and without a chronic disease. Fatigued patients without a chronic disease (cancer survivors, CFS patients and employees) scored significantly higher on Frightening than fatigued patients with a chronic disease (patients with a neuromuscular disorder or pancreatitis).

Do perceptions of fatigue change in patients who recover after treatment for fatigue?

Forty-one fatigued cancer survivors and eighty-two CFS patients were treated for their fatigue complaints with CBT at our department and filled out the FQL at pre- and post treatment. Sensitivity to change of the FQL was demonstrated by dividing the CFS patients and the cancer survivors into two groups: patients who were completely recovered after CBT (CIS-fatigue < 35) and patients who remained fatigued after CBT (CIS-fatigue >= 35). Baseline scores on the four factors were not significantly different between patient who recovered and patients who remained fatigued. The scores on the four factors at pre- and post treatment were compared. Additionally, we compared the post treatment scores on the four factors with the scores of healthy individuals (Table 5). Cancer survivors who were completely recovered after CBT (n = 27) showed a significant decrease on the factors Frustrating, Exhausting and Frightening and a significant increase on the factor Pleasant.

Table 5

Comparison of pre- and post treatment scores on the four factors. Comparison of the post treatment scores with those of healthy individuals

Frustrating

Exhausting

Pleasant

Frightening

Cancer survivors

non fatigued after CBT (n = 27)

pre-treatment

52.6 (27.8)

27.8 (24.4)

11.1 (14.0)

22.2 (23.3)

post-treatment

11.9 (23.0)*

5.6 (20.0)*

36.3 (25.4)*

6.5 (11.2)*

still fatigued after CBT (n = 14)

pre-treatment

67.1 (27.9)

46.4 (30.8)

8.6 (17.0)

19.6 (24.4)

post-treatment

58.6 (34.6)

33.9 (38.7)

7.1 (12.7)

12.5 (19.0)

Chronic Fatigue Syndrome Patients

non fatigued after CBT (n = 47

pre-treatment

60.4 (26.5)

42.0 (31.8)

4.7 (8.6)

20.2 (22.5)

post-treatment

11.1 (18.1)*

3.2 (8.4)*

32.3 (30.5)*

5.9 (11.9)*

still fatigued after CBT (n = 35)

pre-treatment

57.7 (30.6)

44.3 (35.9)

5.1 (11.2)

24.3 (24.6)

post-treatment

45.1 (31.2)

30.0 (33.1)

9.1 (17.0)

12.9 (15.3)*

Healthy individuals

7.7 (18.3)^b,d

3.9 (13.4)^b,d

36.2 (23.3)^b,d

3.2 (10.2)^b,d

CBT = cognitive behaviour therapy

* significant difference between pre- and post treatment scores, Wilcoxon signed rank test p < 0.01

a. significantly different from post treatment scores of group A, Mann-Whitney-U test p < 0.01

b. significantly different from post treatment scores of group B, Mann-Whitney-U test p < 0.01

c. significantly different from post treatment scores of group C, Mann-Whitney-U test p < 0.01

d. significantly different from post treatment scores of group D, Mann-Whitney-U test p < 0.01

The post-treatment scores were not significantly different from those of healthy individuals. In contrast, the cancer survivors who still remained fatigued after CBT (n = 14) did not show a change in the scores on the four factors from pre- to post treatment. Furthermore, their scores at post treatment were significantly different from the scores of healthy individuals. In investigating CFS patients who recovered after CBT (n = 47) the same pattern was found. They also decreased significantly on the factors Frustrating, Exhausting and Frightening and increased significantly on the factor Pleasant. The scores at post treatment were not significantly different from those of healthy individuals. CFS patients who were not recovered after CBT (n = 35) showed no change between pre- and post treatment scores on the factors Frustrating, Exhausting and Pleasant. Although a significant decrease was seen on the factor Frightening, the post treatment scores of the four factors were significantly different form those of healthy individuals.

Discussion

The present study shows that the FQL provides a self report instrument that assesses the perceptions of fatigue. The FQL consists of four coherent factors, namely Frustrating, Exhausting, Pleasant and Frightening. The stable pattern of these factors was indicated with a confirmatory factor analyses, revealing an invariant internal structure in a second group of patients. Furthermore, the data of this study show that the FQL has adequate psychometric properties. Both the intercorrelations and the correlations of the four factors with the subscale CIS-fatigue were not to the extent that the factors could be seen as a parallel test, thus supporting the relative uniqueness of each factor.

The assumption that fatigue is experienced differently by everybody is confirmed with the data of this study. Severely fatigued patients had different perceptions of fatigue compared to healthy individuals. The healthy persons described fatigue as temporary, relaxing, fulfilling, normal and pleasant. None of these adjectives were chosen by 70% of the severely fatigued patients. Even patients with similar fatigue severity, appreciated fatigued differently. Different patterns were seen on the four factors of the FQL between the different populations of patients experiencing fatigue. CFS patients and severely fatigued employees had the highest score on the factors Frustrating, Exhausting and Frightening and also the lowest score on the factor Pleasant in contrast with the other fatigued groups. Until now the underlying aetiology of CFS still remains unclear 2122. Because the patients can not attribute their fatigue to a distinct cause, it's possible that they are more focussed on their fatigue and perceive their fatigue in a more negative way, than the other groups. In agreement with this finding, Moss-Morris et al. 23 found that CFS patients had a more negative view about their symptoms than patients with Rheumatoid arthritis (RA). Additionally, Taillefer et al. 24 found higher levels of illness worry in CFS patients than MS patients who were fatigued. Results of the FQL also showed that patients with a current chronic disease experience their fatigue as less frightening than patients with no current or a past disease. It is possible that these patients attribute their fatigue to their illness and therefore perceive it as less frightening. Cancer survivors may experience fatigue as highly anxiety provoking because they can see fatigue as a symptom for disease-recurrence. Therefore fatigue can be labelled as frightening 25. Future research is necessary to examine if the FQL is applicable for individual assessment and furthermore investigate what the effect of these different perceptions is on the management of fatigue complaints in the clinical practice.

To reach recovery not only a decrease in fatigue severity is important, it is also important that a change in the evaluation of fatigue in the patient occurs. As fatigue is also a part of normal health, being recovered also includes feeling tired sometimes. This makes it difficult to decide where experiencing fatigue as a sign of illness ends and the experience of normal health surfaces. During CBT patients learn that fatigue may occur as part of normal healthy life. When a decrease is seen in the fatigue severity of a patient and the evaluation of the fatigue stays negative, it implicates that a patients still suffers and is disabled due to the fatigue. The patient cannot be seen as fully recovered 26. The results of this study showed that the FQL can demonstrate change in fatigue perceptions following treatment of fatigue. Patients who were recovered after CBT had the same scores on all four factors compared to healthy persons. So, not only the fatigue severity changed after therapy but also the evaluation of fatigue. The FQL can therefore be a helpful tool to define full recovery in the clinical practice.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

MG contributed to conception and design, data collection, data analysis and interpretation, drafting the manuscript, writing the manuscript. HK contributed to data collection, was involved in drafting the manuscript and revising the manuscript. PS contributed to data collection and was involved in drafting the manuscript and revising the manuscript. JK contributed to data collection and revising the manuscript. MH contributed to data collection and revising the manuscript. CV contributed to interpretation of the data and revising the manuscript. GB was involved in the conception and design, drafting the manuscript, interpretation of the data and revising the manuscript. All authors have given approval to the version to be published

Appendix A

Fatigue quality list – FQL

Fatigue can be described in different ways. (see table 6 for form)

Table 6

Fatigue Quality List

Fatigue can be described in different ways. The adjectives below can be seen as descriptions of fatigue.

Please indicate which adjectives accurately describe the fatigue you experienced during the last two weeks by marking them with a cross.

upsetting

persistent

discouraging

frustrating

temporary

relaxing

exhausting

inexplicable

incessant

fulfilling

wearisome

insuperable

frightening

unbearable

annoying

normal

extreme

pleasant

Scoring FQL

Subsequently the four factors are calculated by summing the respective items (0 – 100):

Factor 1: Frustrating

Score of each item: 20

Adjectives: discouraging, incessant, annoying, persistent, frustrating

Factor 2: Exhausting

Score of each item: 25

Adjectives: exhausting, wearisome, extreme, unbearable

Factor 3: Pleasant

Score of each item: 20

Adjectives: temporary, relaxing, fulfilling, normal, pleasant

Factor 4: Frightening

Score of each item: 25

Adjectives: upsetting, frightening, inexplicable, insuperable

Dimensional assessment of Chronic Fatigue Syndrome Vercoulen JHHM Swanink CMA Fennis JFM Galama JMD van der Meer JWM Bleijenberg G J Psychosom Res 1994 38 383 392 10.1016/0022-3999(94)90099-X 7965927 The measurement of fatigue in multiple sclerosis: a comparison with patients with chronic fatigue syndrome and healthy subjects Vercoulen JHMM Hommes OR Swanink CMA Jongen PJH Fennis JFM Galama JMD van der Meer JWM Bleijenberg G Arch Neurol 1996 53 642 649 8929171 Determinants of chronic fatigue in disease-free breast cancer patients, a cross-sectional study Servaes P Verhagen C Bleijenberg G Ann Onco 2002 13 4 589 598 10.1093/annonc/mdf082 Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial Prins JB Bleijenberg G Bazelmans E Elving L de Boo Th Severens JL van der Wilt GJ Spinhoven Ph van der Meer JWM Lancet 2001 357 841 847 10.1016/S0140-6736(00)04198-2 11265953 Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I Kalkman JS Schillings ML van der Werf SP Zwarts MJ van Engelen BGM Bleijenberg G J Neurol Neurosurg Psychiatry 2005 76 1406 1409 10.1136/jnnp.2004.050005 16170086 The experience of severe fatigue long after stroke and its relation with depressive symptoms and disease characteristics Werf SP van der Broek van den H Anten H Bleijenberg G Eur Neurol 2001 45 6 12 10.1159/000052085 11150834 Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences Servaes P Prins J Verhagen C Bleijenberg G J Psychosom Res 2002 52 451 457 10.1016/S0022-3999(02)00300-8 Myalgic: Encephalomyelitis and the medical encounter Cooper L Sociol Health Ill 1997 19 17 37 Chronic debilitating fatigue in Irish general practice: A survey of general practitioners experience Fitzgibbon EJ Murphy EJ O'Shea K Kelleher C Brit J Gen Pract 1997 47 618 622 Patient's perceptions of medical care in chronic fatigue syndrome Deale A Wessely S Soc Sci Med 2001 52 1859 1864 10.1016/S0277-9536(00)00302-6 11352411 The assessment of fatigue. A practical guide for clinicians and researchers Dittner AJ Wessely SC Brown RG J Psychosomatic Res 2004 56 157 170 10.1016/S0022-3999(03)00371-4 On the language of pain Melzack R Torgerson WS Anesthesiology 1971 34 50 59 4924784 The McGill Pain Questionnaire: from description to measurement Melzack R Anesthesiology 2005 103 199 202 10.1097/00000542-200507000-00028 15983473 De Checklist Individual Strength (CIS) Vercoulen JHMM Alberts M Bleijenberg G Gedragstherapie 1999 32 131 136 Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy : A randomized controlled trial Gielissen MFM Verhagen C Witjes JA Bleijenberg G J Clin Oncol 2006 24 30 4882 4887 10.1200/JCO.2006.06.8270 17050873 The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome-a double blind randomized controlled trial Brouwers FM van der Werf S Bleijenberg G van der Zee L van der Meer JWM Q J Med 2002 95 10 677 683 Efficacy of cognitive-behavioural therapy by general practitioners for unexplained fatigue among employees: Randomised controlled trial Huibers MJH Beurskens AJHM van Schayck CP Bazelmans E Metsemakers JFM Knottnerus JA Bleijenberg G Br J Psychiatry 2004 184 240 246 10.1192/bjp.184.3.240 14990522 Fatigue in neuromuscular diseases, a comparison with multiple sclerosis Van der Werf SP van Engelen B Kalkman J Schillings M Jongen P Zwarts M Bleijenberg G Determinants and consequences of experienced fatigue in chronic fatigue syndrome and neurological conditions. Dissertation KUN Van der Werf SP 2003 Arbuckle JL Amos 4.0. User's guide Chicago, IL: SmallWaters Corporation 1994 Some empirical evidence regarding the validity of the Spanish Version of the McGill Pain Questionnaire (MPQ-SV) Masedo AI Esteve R Pain 2000 85 451 456 10.1016/S0304-3959(99)00300-0 10781918 Review : Chronic fatigue syndrome Prins JB van der Meer JWM Bleijenberg G Lancet 2006 367 346 355 10.1016/S0140-6736(06)68073-2 16443043 Chronic fatigue syndrome : an update focusing on phenomenology and pathophysiology Cho HJ Skowera A Cleare A Wessely S Curr Opin Psychiatry 2006 19 67 73 10.1097/01.yco.0000194370.40062.b0 16612182 Illness perceptions and levels of disability in patients with chronic fatigue syndrome and rheumatoid arthritis Moss-Morris R Chalder T J Psychosom Res 2003 54 331 337 10.1016/S0022-3999(02)00332-X 12670610 Correlates of illness worry in chronic fatigue syndrome Taillefer SS Kirmayer LJ Robbines JM Lasry JC J Psychosom Res 2003 55 305 308 10.1016/S0022-3999(03)00013-8 14507540 Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors Gil KM Mishel MH Belyea M Germino B Porter LS LaNey IC Stewart J Onco Nurs Forum 2004 31 3 633 639 Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? Knoop H Bleijenberg G Gielissen MFM Van der Meer JWM White PD Psychother Psychosom 2007 76 171 176 10.1159/000099844 17426416